211 related articles for article (PubMed ID: 28397718)
1. Clinical Predictors of Outcome in Patients with Anti-neutrophil Cytoplasmic Autoantibody-related Renal Vasculitis: Experiences from a Single-center.
Pu L; Li GS; Zou YR; Zhang P; Wang L
Chin Med J (Engl); 2017 Apr; 130(8):899-905. PubMed ID: 28397718
[TBL] [Abstract][Full Text] [Related]
2. Predictors for mortality in patients with antineutrophil cytoplasmic autoantibody-associated vasculitis: a study of 398 Chinese patients.
Lai QY; Ma TT; Li ZY; Chang DY; Zhao MH; Chen M
J Rheumatol; 2014 Sep; 41(9):1849-55. PubMed ID: 25086076
[TBL] [Abstract][Full Text] [Related]
3. The BVAS is an independent predictor of cardiovascular events and cardiovascular disease-related mortality in patients with ANCA-associated vasculitis: A study of 504 cases in a single Chinese center.
Bai YH; Li ZY; Chang DY; Chen M; Kallenberg CG; Zhao MH
Semin Arthritis Rheum; 2018 Feb; 47(4):524-529. PubMed ID: 28917713
[TBL] [Abstract][Full Text] [Related]
4. Clinical, serological and histological determinants of patient and renal outcome in ANCA-associated vasculitis with renal involvement: an analysis from a referral centre.
Crnogorac M; Horvatic I; Toric L; Galesic Ljubanovic D; Tisljar M; Galesic K
Int Urol Nephrol; 2017 Aug; 49(8):1419-1431. PubMed ID: 28646482
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of Elderly Patients with Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitis Treated with Immunosuppressive Therapy.
Judge PK; Reschen ME; Haynes R; Sharples EJ
Nephron; 2016; 133(4):223-31. PubMed ID: 27433990
[TBL] [Abstract][Full Text] [Related]
6. Simple, readily available clinical indices predict early and late mortality among patients with ANCA-associated vasculitis.
Haris Á; Polner K; Arányi J; Braunitzer H; Kaszás I; Rosivall L; Kökény G; Mucsi I
BMC Nephrol; 2017 Feb; 18(1):76. PubMed ID: 28231769
[TBL] [Abstract][Full Text] [Related]
7. The risk factors for early mortality and end-stage renal disease in anti-neutrophil cytoplasmic antibody-associated glomerulonephritis: experiences from a single center.
Ni A; Chen L; Huang X; Ma Y; Lan L; Ren P; Wang Y; Zhu Y; Xu Y; Chen J; Han F
Clin Exp Med; 2021 Aug; 21(3):389-397. PubMed ID: 33768341
[TBL] [Abstract][Full Text] [Related]
8. Anti-neutrophil cytoplasmic antibody-associated vasculitis with renal involvement: Analysis of 89 cases.
Caravaca-Fontán F; Yerovi E; Delgado-Yagu E M; Galeano C; Pampa-Saico S; Tenorio MT; Liaño F
Med Clin (Barc); 2017 Jan; 148(1):1-7. PubMed ID: 28196580
[TBL] [Abstract][Full Text] [Related]
9. The neutrophil-to-lymphocyte ratio as a marker of vasculitis activity, severe infection and mortality in anca-associated vasculitis: A retrospective study.
Fonseca JA; Gameiro J; Duarte I; Jorge S; Lopes JA
Nefrologia (Engl Ed); 2021; 41(3):321-328. PubMed ID: 33309337
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the risk factors for end‑stage renal disease and mortality in ANCA-associated vasculitis: a study from a single center of the Chinese Rheumatism Data Center.
Guo Q; Yu L; Zhang X; Shang J; Duan X
Clin Rheumatol; 2023 Feb; 42(2):489-499. PubMed ID: 36367596
[TBL] [Abstract][Full Text] [Related]
11. The neutrophil-to-lymphocyte ratio as a marker of vasculitis activity, severe infection and mortality in anca-associated vasculitis: A retrospective study.
Fonseca JA; Gameiro J; Duarte I; Jorge S; Lopes JA
Nefrologia (Engl Ed); 2021; 41(3):321-328. PubMed ID: 36165341
[TBL] [Abstract][Full Text] [Related]
12. A new vasculitis activity score for predicting death in myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis patients.
Koike K; Fukami K; Yonemoto K; Iwatani R; Obata R; Ueda K; Toyonaga M; Ueda S; Ohara A; Takeda K; Yamagishi S; Okuda S
Am J Nephrol; 2012; 35(1):1-6. PubMed ID: 22134171
[TBL] [Abstract][Full Text] [Related]
13. Trends in Long-Term Outcomes Among Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis With Renal Disease.
Rhee RL; Hogan SL; Poulton CJ; McGregor JA; Landis JR; Falk RJ; Merkel PA
Arthritis Rheumatol; 2016 Jul; 68(7):1711-20. PubMed ID: 26814428
[TBL] [Abstract][Full Text] [Related]
14. The association of neutrophil-to-lymphocyte ratio with all-cause mortality in Chinese patients with MPO-ANCA associated vasculitis.
Huang L; Shen C; Zhong Y; Ooi JD; Zhou YO; Chen JB; Wu T; Meng T; Xiao Z; Lin W; Ao X; Tang R; Xiao X; Zhou Q; Xiao P
Clin Exp Med; 2020 Aug; 20(3):401-408. PubMed ID: 32318926
[TBL] [Abstract][Full Text] [Related]
15. Platelet to lymphocyte ratio is associated with the current activity of ANCA-associated vasculitis at diagnosis: a retrospective monocentric study.
Park HJ; Jung SM; Song JJ; Park YB; Lee SW
Rheumatol Int; 2018 Oct; 38(10):1865-1871. PubMed ID: 30088046
[TBL] [Abstract][Full Text] [Related]
16. Systemic immune-inflammation index could estimate the cross-sectional high activity and the poor outcomes in immunosuppressive drug-naïve patients with antineutrophil cytoplasmic antibody-associated vasculitis.
Kim Y; Choi H; Jung SM; Song JJ; Park YB; Lee SW
Nephrology (Carlton); 2019 Jul; 24(7):711-717. PubMed ID: 30203901
[TBL] [Abstract][Full Text] [Related]
17. [A preliminary study of the significance of autoantibodies against light chain of myeloperoxidase on pulmonary damages in myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis].
Zhang L; Shuai Z; Hu Z; Zhang M; Chen S
Zhonghua Nei Ke Za Zhi; 2015 Jun; 54(6):511-6. PubMed ID: 26359012
[TBL] [Abstract][Full Text] [Related]
18. Low serum complement 3 level is associated with severe ANCA-associated vasculitis at diagnosis.
Choi H; Kim Y; Jung SM; Song JJ; Park YB; Lee SW
Clin Exp Nephrol; 2019 Feb; 23(2):223-230. PubMed ID: 30168048
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy of protein A immunoadsorption therapy on severe ANCA-associated vasculitis renal injury.
Song J; Liu H; Chen X; Zhou L; Sun C; Yuan F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Jul; 48(7):1026-1032. PubMed ID: 37724405
[TBL] [Abstract][Full Text] [Related]
20. The CD4 Lymphocyte Count is a Better Predictor of Overall Infection Than the Total Lymphocyte Count in ANCA-Associated Vasculitis Under a Corticosteroid and Cyclophosphamide Regimen: A Retrospective Cohort.
Shi YY; Li ZY; Zhao MH; Chen M
Medicine (Baltimore); 2015 May; 94(18):e843. PubMed ID: 25950695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
